Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
International Journal of Molecular Sciences|April 3, 2021
Impact of BMI on Survival Outcomes of Immunotherapy in Solid Tumors: A Systematic ReviewAlice Indini, Erika Rijavec, Michele Ghidini, et al.
Expert Opinion on Pharmacotherapy|March 13, 2020
Pharmacotherapeutic advances with anaplastic lymphoma kinase inhibitors for the treatment of non-small cell lung cancerAlice Indini, Erika Rijavec, Michele Ghidini, et al.
Expert Opinion on Pharmacotherapy|November 15, 2016
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancerCarlo Genova, Erika Rijavec, Federica Biello, et al.
Frontiers in Oncology|September 20, 2014
Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch SystemAnna Truini, Angela Alama, Maria Giovanna Dal Bello, et al.
Expert Opinion on Pharmacotherapy|October 26, 2018
The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancerGiovanni Rossi, Angela Alama, Carlo Genova, et al.
Anti-Cancer Drugs|August 2, 2007
Anthracyclines and taxanes induce the upregulation of thymidine phosphorylase in breast cancer cellsFabio Puglisi, Claudia Andreetta, Francesca Valent, et al.
Lung Cancer (Amsterdam, Netherlands)|February 4, 2018
Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapyFrancesco Grossi, Carlo Genova, Erika Rijavec, et al.
Expert Opinion on Pharmacotherapy|November 6, 2018
Afatinib and Erlotinib in the treatment of squamous-cell lung cancerMarco Tagliamento, Carlo Genova, Erika Rijavec, et al.
Expert Opinion on Pharmacotherapy|March 21, 2014
Afatinib for the treatment of advanced non-small-cell lung cancerCarlo Genova, Erika Rijavec, Giulia Barletta, et al.
Pageof 10